Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Leukemia ; 20(6): 1035-9, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16572205

RESUMO

In chronic myeloid leukaemia, CD34(+) stem/progenitor cells appear resistant to imatinib mesylate (IM) in vitro and in vivo. To investigate the underlying mechanism(s) of IM resistance, it is essential to quantify Bcr-Abl kinase status at the stem cell level. We developed a flow cytometry method to measure CrkL phosphorylation (P-CrkL) in samples with <10(4) cells. The method was first validated in wild-type (K562) and mutant (BAF3) BCR-ABL(+) as well as BCR-ABL(-) (HL60) cell lines. In response to increasing IM concentration, there was a linear reduction in P-CrkL, which was Bcr-Abl specific and correlated with known resistance. The results were comparable to those from Western blotting. The method also proved to be reproducible with small samples of normal and Ph(+) CD34(+) cells and was able to discriminate between Ph(-), sensitive and resistant Ph(+) cells. This assay should now enable investigators to unravel the mechanism(s) of IM resistance in stem cells.


Assuntos
Proteínas Adaptadoras de Transdução de Sinal/metabolismo , Antígenos CD34/biossíntese , Resistencia a Medicamentos Antineoplásicos , Proteínas de Fusão bcr-abl/metabolismo , Células-Tronco Hematopoéticas/metabolismo , Leucemia Mielogênica Crônica BCR-ABL Positiva/metabolismo , Proteínas Nucleares/metabolismo , Piperazinas/farmacologia , Pirimidinas/farmacologia , Benzamidas , Linhagem Celular Tumoral , Relação Dose-Resposta a Droga , Citometria de Fluxo/métodos , Proteínas de Fusão bcr-abl/efeitos dos fármacos , Proteínas de Fusão bcr-abl/genética , Células HL-60 , Humanos , Mesilato de Imatinib , Técnicas In Vitro , Células K562 , Fosforilação , Sensibilidade e Especificidade , Células Tumorais Cultivadas
2.
Cell Death Differ ; 12(5): 415-28, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15746942

RESUMO

Hyperosmotic shock, energy depletion, or removal of extracellular Cl(-) activates Ca(2+)-permeable cation channels in erythrocyte membranes. Subsequent Ca(2+) entry induces erythrocyte shrinkage and exposure of phosphatidylserine (PS) at the erythrocyte surface. PS-exposing cells are engulfed by macrophages. The present study explored the signalling involved. Hyperosmotic shock and Cl(-) removal triggered the release of prostaglandin E(2) (PGE(2)). In whole-cell recording, activation of the cation channels by Cl(-) removal was abolished by the cyclooxygenase inhibitor diclophenac. In FACS analysis, phospholipase-A(2) inhibitors quinacrine and palmitoyltrifluoromethyl-ketone, and cyclooxygenase inhibitors acetylsalicylic acid and diclophenac, blunted the increase of PS exposure following Cl(-) removal. PGE(2) (but not thromboxane) induced cation channel activation, increase in cytosolic Ca(2+) concentration, cell shrinkage, PS exposure, calpain activation, and ankyrin-R degradation. The latter was attenuated by calpain inhibitors-I/II, while PGE(2)-induced PS exposure was not. In conclusion, hyperosmotic shock or Cl(-) removal stimulates erythrocyte PS exposure through PGE(2) formation and subsequent activation of Ca(2+)-permeable cation channels.


Assuntos
Apoptose/efeitos dos fármacos , Eritrócitos/efeitos dos fármacos , Prostaglandinas E/metabolismo , Anquirinas/metabolismo , Anexinas/metabolismo , Cálcio/metabolismo , Canais de Cálcio/efeitos dos fármacos , Calpaína/metabolismo , Tamanho Celular/efeitos dos fármacos , Cloretos/metabolismo , Inibidores de Ciclo-Oxigenase/farmacologia , Citosol/efeitos dos fármacos , Diclofenaco/farmacologia , Inibidores Enzimáticos/farmacologia , Citometria de Fluxo , Humanos , Modelos Biológicos , Pressão Osmótica/efeitos dos fármacos , Técnicas de Patch-Clamp , Fosfatidilserinas/metabolismo , Fosfolipases A/metabolismo , Prostaglandinas E/farmacologia , Quinacrina/farmacologia , Solução Salina Hipertônica
3.
Cell Death Differ ; 10(2): 249-56, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12700653

RESUMO

Erythrocytes are devoid of mitochondria and nuclei and were considered unable to undergo apoptosis. As shown recently, however, the Ca(2+)-ionophore ionomycin triggers breakdown of phosphatidylserine asymmetry (leading to annexin binding), membrane blebbing and shrinkage of erythrocytes, features typical for apoptosis in nucleated cells. In the present study, the effects of osmotic shrinkage and oxidative stress, well-known triggers of apoptosis in nucleated cells, were studied. Exposure to 850 mOsm for 24 h, to tert-butyl-hydroperoxide (1 mM) for 15 min, or to glucose-free medium for 48 h, all elicit erythrocyte shrinkage and annexin binding, both sequelae being blunted by removal of extracellular Ca(2+) and mimicked by ionomycin (1 microM). Osmotic shrinkage and oxidative stress activate Ca(2+)-permeable cation channels and increase cytosolic Ca(2+) concentration. The channels are inhibited by amiloride (1 mM), which further blunts annexin binding following osmotic shock, oxidative stress and glucose depletion. In conclusion, osmotic and oxidative stress open Ca(2+)-permeable cation channels in erythrocytes, thus increasing cytosolic Ca(2+) activity and triggering erythrocyte apoptosis.


Assuntos
Apoptose/efeitos dos fármacos , Cátions/metabolismo , Eritrócitos/fisiologia , Canais Iônicos/fisiologia , Estresse Oxidativo/fisiologia , Amilorida/farmacologia , Anexinas/metabolismo , Apoptose/fisiologia , Cálcio/farmacocinética , Contagem de Células , Tamanho Celular/efeitos dos fármacos , Citosol/química , Citosol/efeitos dos fármacos , Eritrócitos/citologia , Eritrócitos/efeitos dos fármacos , Eritrócitos/metabolismo , Glucose/metabolismo , Humanos , Canais Iônicos/antagonistas & inibidores , Ionomicina/farmacologia , Ionóforos/farmacologia , Pressão Osmótica/efeitos dos fármacos , Técnicas de Patch-Clamp , terc-Butil Hidroperóxido/farmacologia
4.
Cell Death Differ ; 11(2): 231-43, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-14615798

RESUMO

Erythrocytes lack nuclei and mitochondria, the organelles important for apoptosis of nucleated cells. However, following increase of cytosolic Ca(2+) activity, erythrocytes undergo cell shrinkage, cell membrane blebbing and breakdown of phosphatidylserine asymmetry, all features typical for apoptosis in nucleated cells. The same events are observed following osmotic shock, an effect mediated in part by activation of Ca(2+)-permeable cation channels. However, erythrocyte death following osmotic shock is blunted but not prevented in the absence of extracellular Ca(2+) pointing to additional mechanisms. As shown in this study, osmotic shock (950 mOsm) triggers sphingomyelin breakdown and formation of ceramide. The stimulation of annexin binding following osmotic shock is mimicked by addition of ceramide or purified sphingomyelinase and significantly blunted by genetic (aSM-deficient mice) or pharmacologic (50 microM 3,4-dichloroisocoumarin) knockout of sphingomyelinase. The effect of ceramide is blunted but not abolished in the absence of Ca(2+). Conversely, osmotic shock-induced annexin binding is potentiated in the presence of sublethal concentrations of ceramide. In conclusion, ceramide and Ca(2+) entry through cation channels concert to trigger erythrocyte death during osmotic shock.


Assuntos
Ceramidas/metabolismo , Eritrócitos/citologia , Eritrócitos/metabolismo , Animais , Anexinas/metabolismo , Cálcio/metabolismo , Caspases/metabolismo , Morte Celular/efeitos dos fármacos , Tamanho Celular/efeitos dos fármacos , Ceramidas/biossíntese , Ceramidas/farmacologia , Cumarínicos/farmacologia , Eritrócitos/efeitos dos fármacos , Fumonisinas/farmacologia , Humanos , Ionomicina/farmacologia , Isocumarinas , Camundongos , Camundongos Knockout , Pressão Osmótica/efeitos dos fármacos , Ligação Proteica/efeitos dos fármacos , Esfingomielina Fosfodiesterase/antagonistas & inibidores , Esfingomielina Fosfodiesterase/genética , Esfingomielina Fosfodiesterase/metabolismo , Esfingomielinas/metabolismo
5.
Naunyn Schmiedebergs Arch Pharmacol ; 367(4): 391-6, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12690431

RESUMO

Even though lacking mitochondria and nuclei erythrocytes do undergo apoptotic cell death which is characterized by breakdown of phosphatidylserine asymmetry (leading to annexin binding), membrane blebbing and cell shrinkage. Previously, we have shown that erythrocyte apoptosis is triggered by osmotic shrinkage at least in part through activation of cell volume-sensitive cation channels and subsequent Ca2+ entry. The channels could not only be activated by cell shrinkage but as well by replacement of Cl- with gluconate. Both, channel activity and annexin binding were sensitive to high concentrations of amiloride (1 mM). The present study has been performed to search for more effective blockers. To this end channel activity has been evaluated utilizing whole-cell patch-clamp and annexin binding determined by FACS analysis as an indicator of erythrocyte apoptosis. It is shown that either, increase of osmolarity or replacement of Cl- by gluconate triggers the activation of the cation channel which is inhibited by amiloride at 1 mM but not at 100 microM. Surprisingly, the cation channel was significantly more sensitive to the amiloride analogue ethylisopropylamiloride (EIPA, IC(50)=0.6+/-0.1 microM, n=5). Exposure of the cells to osmotic shock by addition of sucrose (850 mOsm) led to stimulation of annexin binding which was inhibited similarly by EIPA (IC(50)=0.2+/-0.2 microM, n=4). Moreover, annexin binding was inhibited by higher concentrations of HOE 642 (IC(50)=10+/-5 microM, n=5) and HOE 694 (IC(50)=12+/-6 microM, n=4). It is concluded that osmotic shock stimulates a cation channel which participates in the triggering of erythrocyte apoptosis. EIPA is an effective inhibitor of this cation channel and of channel mediated triggering of erythrocyte apoptosis.


Assuntos
Amilorida/análogos & derivados , Amilorida/farmacologia , Apoptose/efeitos dos fármacos , Eritrócitos/fisiologia , Canais Iônicos/antagonistas & inibidores , Amilorida/administração & dosagem , Anexinas/metabolismo , Apoptose/fisiologia , Cátions/metabolismo , Tamanho Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Eritrócitos/citologia , Eritrócitos/metabolismo , Guanidinas/farmacologia , Humanos , Técnicas In Vitro , Canais Iônicos/metabolismo , Canais Iônicos/fisiologia , Pressão Osmótica/efeitos dos fármacos , Técnicas de Patch-Clamp , Sulfonas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA